Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.
It is critical for physicians to urge patients with obesity to get vaccinated against COVID-19 as they are one of the highest risk patient populations.
At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.
Experts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.
These tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.
Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.
Obesity affects nearly 20% of US children, impacting both current and future health. The 2020 update of the Pediatric Obesity Algorithm provides expert treatment guidance.
Students from the Medical College of Georgia, unable to care directly for COVID-19 patients, combined their individual skills to keep accurate information flowing.
The oral calcitonin gene-related peptide receptor antagonist is now indicated for prevention in both episodic and chronic migraine.
What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.
Mental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.
An obesity specialist explains why clinicians should start at the root cause when managing patients with type 2 diabetes and obesity.
To be marketed as Rizafilm, the product is a disintegrating film formulation of the 5-HT-1 receptor antagonist and proven bioequivalent to Merck's Maxalt-MLT.
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
The findings come from an analysis of data related to more than 80 000 participants in the Women's Health Initiative Observational Study.
Social determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?
AHA Scientific Sessions 2021 recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
The pandemic has altered how patients access and use health care. Now is the time for primary care clinicians to rebuild important connections with them.
Consider all the first year medical students introduced to patient care in 2020 via computer screens and monitors. A young telehealth native tells her story.
Among patients with COPD and OSA, those with consistent CPAP compliance over 12 months showed improved lung function and experienced fewer AECOPD.
Dr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.
Experts provide an overview of a study on the use of the OneTouch Verio Flex meter paired with the OneTouch Reveal mobile application in the management of diabetes.
COVID-19 has dealt in-person addiction treatment a blow, but the chief medical officer of Groups Recover Together tells a telemedicine success story with a hybrid ending.
Train your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.
Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Beginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.